DEPDC1癌抗原在恶性胶质瘤及脑肿瘤起始细胞中的功能分析
该研究分析DEPDC1在恶性胶质瘤中的表达与功能,发现DEPDC1在胶质瘤细胞系、组织及脑肿瘤起始细胞(BTIC)中表达升高;siRNA抑制DEPDC1可降低胶质瘤细胞活力并经NFκB信号诱导凋亡,在小鼠胶质瘤模型中下调DEPDC1延长总生存期。
要点
- DEPDC1在胶质瘤细胞系、组织和脑肿瘤起始细胞中表达升高。
- siRNA抑制DEPDC1可降低胶质瘤细胞活力,并经NFκB信号诱导凋亡。
- 在人胶质瘤细胞及诱导小鼠脑肿瘤干细胞模型中,下调DEPDC1延长总生存期。
核心结论
- DEPDC1是胶质瘤治疗的候选靶分子。
研究设计与样本
- 实验研究:检测胶质瘤细胞系、胶质瘤组织及脑肿瘤起始细胞(BTIC)中DEPDC1表达,并用siRNA敲低后观察细胞活力、凋亡及NFκB信号,再在人胶质瘤细胞和诱导小鼠脑肿瘤干细胞(imBTSC)小鼠模型中评估总生存期。
主要发现
- DEPDC1在胶质瘤细胞系、组织和BTIC中表达升高。
- siRNA抑制内源性DEPDC1降低胶质瘤细胞活力,并经NFκB信号诱导凋亡。
- 在人胶质瘤细胞和imBTSC小鼠胶质瘤模型中,下调DEPDC1表达延长总生存期。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
DEP domain containing 1 (DEPDC1) is a novel oncoantigen expressed in cancer cells, which presents oncogenic activity and high immunogenicity. Although DEPDC1 has been predicted to be a useful antigen for the development of a cancer vaccine, its pathophysiological roles in glioma have not been investigated. Here, we analyzed the expression and function of DEPDC1 in malignant glioma. DEPDC1 expression in glioma cell lines, glioma tissues, and brain tumor initiating cells (BTICs) was assessed by western blot and quantitative polymerase chain reaction (PCR). The effect of DEPDC1 downregulation on cell growth and nuclear factor kappa B (NFκB) signaling in glioma cells was investigated. Overall survival was assessed in mouse glioma models using human glioma cells and induced mouse brain tumor stem cells (imBTSCs) to determine the effect of DEPDC1 suppression in vivo. DEPDC1 expression was increased in glioma cell lines, tissues, and BTICs. Suppression of endogenous DEPDC1 expression by small interfering RNA (siRNA) inhibited glioma cell viability and induced apoptosis through NFκB signaling. In mouse glioma models using human glioma cells and imBTSCs, downregulation of DEPDC1 expression prolonged overall survival. These results suggest that DEPDC1 represents a target molecule for the treatment of glioma.
引用
- Kikuchi R, Sampetrean O, Saya H, et al. Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells. J Neurooncol. 2017. PMID: 28555424. doi:10.1007/s11060-017-2457-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。